Nonalcoholic Steatohepatitis: Involvement of the Telomerase and Proinflammatory Mediators

Figure 2

Levels of S100A8, S100A9, and S100A9/A9 in the serum of NASH and NASH patients with fibrosis in comparison with healthy controls. S100A8 was measured by ELISA as described in Section 2. Data represent mean ± SEM in triplicate (ELISA) from 39 different donors’ serum from NASH patients and healthy volunteers. (a) S100A8 in NASH patients with fibrosis was significantly increased. Unpaired -test; . (b) S100A9 in NASH and NASH patients with fibrosis was significantly increased. Unpaired -test; and , respectively. (c) S100A8/A9 in NASH and NASH patients with fibrosis was significantly increased. Unpaired -test; and , respectively ().

(a)

(b)

(c)